Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 52, Issue 23, Pages 7724-7731Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm9007483
Keywords
-
Categories
Funding
- NIH [DA04087, DA03910, DA007281, DA007267]
Ask authors/readers for more resources
Chronic use of mu-opioid agonists has been shown to cause neurochemical adaptations resulting in tolerance and dependence, While the analgesic effects of these drugs are mediated by mu-opioid receptors (MOR), several studies have shown that antagonism or knockdown of delta-opioid receptors (DOR) can lessen or prevent development of tolerance and dependence. On the basis of computational modeling of putative active and inactive conformations of MOR and DOR, we have synthesized a series of pentapeptides with the goal of developing a MOR agonist/DOR antagonist peptide with similar affinity at both receptors as a tool to probe functional opioid receptor interaction(s). The eight resulting naphthylalanine-substituted cyclic pentapeptides displayed variable mixed-efficacy profiles. The most promising peptide (9; Tyr-c(S-CH2-S)[D-Cys-Phe-2-Nal-Cys]NH2) displayed it MOR agonist and DOR partial agonist/antagonist profile and bound with equipotent affinity (K-i similar to 0.5 nM) to both receptors, but also Showed K opioid receptor (KOR) agonist activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available